WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'9401 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 8'6021 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 6'345  6'312  6'281  6'251  6'221  5'868  5'255  4'581 
Births 118  118  118  119  119  146  164  171 
Surviving infants 116  116  117  117  117  142  156  156 
Pop. less than 5 years 577  580  585  594  602  749  744  757 
Pop. less than 15 years 1'763  1'787  1'811  1'843  1'880  2'149  2'099  2'005 
Female 15-49 years 1'785  1'771  1'756  1'739  1'718  1'509  1'295  1'065 

Number of reported cases

(Click for retrospective incidence data for El Salvador)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  2'315 
Mumps
ChartChart
  257  274  351  1'170 
Pertussis
ChartChart
  13  37  1'003 
Polio*
ChartChart
  55 
Rubella
ChartChart
  298 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  25  61 
Tetanus (total)**
ChartChart
  13  98 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for El Salvador)
Vaccine year result method % card seen                                                
BCG 2013  98  MICS   90  87  99*  85  90  90  99  75  56 
DTP1 2013  99  MICS   90  90  93  96  91  92  87 
DTP3 2013  94  MICS   90  93  91  94  92  92  99  80  44 
DTP4          90  92  92 
IPV1          90 
HepB_BD          81  75  99* 
HepB3 2013  94  MICS   90  93  91  93  92  92  99 
Hib3 2013  94  MICS   90  93  91  93  92  92 
JapEnc         
MCV1          90  95  95  94  93  97  98  45 
MCV2          87  88  85  85  95 
MenA         
PCV1          88  96  92  91  93 
PCV2          88  99*  86  92  94 
PCV3          90  98  86  92  94 
Pol3 2013  92  MICS   90  95  92  93  92  93  98  80  42 
Rota1          91  95  97  92  93 
RotaC 2013  96  MICS   90  93  93  96  92  93 
RCV1          90  95  94  94  93 
TT2plus          73  94  86  70  26 
PAB          99*  85 
VAD1          20  36  47  57 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for El Salvador)
BCG
ChartChart
  99  99  85  90  90  99  75  56 
DTP1
ChartChart
  97  93  96  97  92  99  93  69 
DTP3
ChartChart
  93  91  94  92  92  99  80  44 
HepB3
ChartChart
  93  91  93  92  92  99 
HepB_BD
ChartChart
  81  75 
Hib3
ChartChart
  93  91  93  92  92 
IPV1
  90 
MCV1
ChartChart
  90  95  95  94  93  97  98  45 
MCV2
ChartChart
  87  88  85  85  95 
PCV3
ChartChart
  90  98  86  92  94 
Pol3
ChartChart
  95  92  93  92  93  98  80  42 
RCV1
ChartChart
  90  95  95  94  93  97 
RotaC
ChartChart
  93  93  96  92  93 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 262  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 17
From 50 to 79% 24
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 year; Yes
DT 2, 4, 6, 12 months; 4 years; Yes allergic to pertussis
DTwP 4 years; Yes
DTwPHibHepB 2, 4, 6, 12 months; Yes
HepB_Adult 1st contact; +2, +6 months; Yes health care workers and risk groups
HepB_Pediatric birth; Yes
Influenza_Adult Yes and health care workers, pregnant women, adults with chronic diseases, and other risk groups
Influenza_Pediatric 6 months to < 5 years; Yes and children with chronic diseases
IPV 2, 4, 6, 12 months, 4 years; Yes from dose at M4 to children with HIV+ mothers
MMR 1, 4 years; Yes
OPV 2, 4, 6, 12 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 10 years; Yes every 10 years
VitaminA < 5 years; Yes
YF No travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019    2013-2014  2009-2014  2009-2014  2009-2014  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 262  262  262  262  262  262  262 

System performance

Total Nº districts in country number 262  262  262  262  262     
Nº districts with DTP3 coverage >=80% number 196  190  207  216  221  202  185 
% of districts with DTP3 coverage >=80% From 0 to 100% 75  73  79  82  84     
Nº districts with measles (MCV1) coverage >=95% number 118  142  131  159  150  119  101 
% of districts with MCV1 coverage >=95% From 0 to 100% 45  54  50  61  57     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 89  100  100  100  99  99  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.